Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma. (Q38529374)
Jump to navigation
Jump to search
scientific article published on February 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma. |
scientific article published on February 1998 |
Statements
Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma (English)
Bischoff ED
Gottardis MM
Moon TE
Heyman RA
1 February 1998